Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Common Warts (Verruca Vulgaris): later-stage trial registry
1 of 2 indexed Common Warts (Verruca Vulgaris) trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Common Warts (Verruca Vulgaris): 2 US clinical trials tracked, 1 recruiting.
Common Warts (Verruca Vulgaris) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Nielsen BioSciences, running 1 of these trials.
Enrollment posture brief
Registry condition common-warts-verruca-vulgaris
OPEN 1 | RECR 50% | LATE 2 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Common Warts (Verruca Vulgaris) lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Common Warts (Verruca Vulgaris) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Common Warts (Verruca Vulgaris) is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Common Warts (Verruca Vulgaris) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Common Warts (Verruca Vulgaris) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Common Warts (Verruca Vulgaris) page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Common Warts (Verruca Vulgaris) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Nielsen BioSciences sponsors the most Common Warts (Verruca Vulgaris) trials on record, review their full trial history before evaluating a specific study. See Nielsen BioSciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Common Warts (Verruca Vulgaris) condition card totals 2 registered trials; most-linked intervention Candin, Intradermal Solution; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.